---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-23-000020"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2023-04-26T23:59:59+00:00"
generated_at: "2026-06-16T14:46:28.125669+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q1 revenue $297.6M (+8% YoY); GAAP EPS $0.36 vs $0.18

## Summary
- Q1 2023 GAAP EPS $0.36, up from $0.18 YoY; non-GAAP EPS $0.64, up from $0.53.
- Revenue $297.6M, +8.0% reported; constant currency organic revenue +9.8%.
- GAAP operating margin 8.9% improved from 5.5%; non-GAAP operating margin 16.1% from 14.6%.
- No forward guidance provided in the release.

## SEC filing metadata
- accession: 0000856982-23-000020
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2023-04-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698223000020/0000856982-23-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698223000020/mmsi-20230426x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-23-000020
- JSON: https://secwatch.observer/filing/0000856982-23-000020.json
- Plain text: https://secwatch.observer/filing/0000856982-23-000020.txt

## Key facts
- Earnings Releases
  MERIT MEDICAL SYSTEMS INC reported financial results for quarter ended March 31, 2023.
  - Period: quarter ended March 31, 2023
  - Result: reported results
  source text: On April 26, 2023, the Company issued a press release announcing its operating and financial results for the quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000020/0000856982-23-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.